The present invention relates to the field of medical devices and, more particularly, to a knitted stent and a knitted stent system.
Peripheral artery disease (PAD) is characterized by atherosclerosis of peripheral arteries, associated with a risk of myocardial infarction, cerebral stroke and vascular death and prevalent in the elderly population. With the development of vascular interventional technology, mainstream surgical PAD treatment has been gradually transitioning from open surgery to endovascular interventional surgery.
Typical interventional surgical procedures for PAD treatment are balloon dilation and stenting procedures. However, as satisfactory long-term outcomes are unachievable only by balloon dilation for most patients, stenting is considered critical for PAD treatment. At present, stents used in PAD treatment are mainly self-expanding ones.
Self-expanding stents can be categorized into laser-cut stents and knitted stents. No matter which of these types is used in a PAD treatment procedure, it is inevitable for the stent to stimulate the inner wall, and cause endothelial hyperplasia, of the blood vessel where it is deployed, which may ultimately develop to vascular restenosis. Currently, this problem is overcome mainly by using the drug-loaded stents. Most existing drug-loaded stents choose laser-cut stents as the drug carriers, in which grooves are engraved and drugs are deposited in the grooves. However, the laser-cut stents are insufficient in geometric compliance and fatigue resistance and tend to break when the blood vessel anatomy requires significant deformation. Knitted stents have good mechanical properties, but forming grooves or holes for receiving drugs in fine wires from which they are knitted is costly or even infeasible. Although it is also contemplated to obtain drug-loaded stents by directly spraying drugs onto wires of knitted stents, the so-formed drug-containing films can easily peel off and tend to not allow sustained drug release.
In order to overcome the above-described problem of difficulty in drug loading with conventional knitted stents, it is an objective of the present invention to provide a knitted stent and a knitted stent system.
The above objective is attained by a knitted stent according to the present invention, which includes a wire spirally coiled about an axis in an interlaced manner, the wire including at least one elastic metal tube each defining a first lumen and having a wall in which release holes in communication with the first lumen are formed.
Optionally, the first lumen may be filled with a drug or a mixture of a drug and a drug carrier.
Optionally, a liner core may be disposed within the first lumen so as to at least partially fill the first lumen.
Optionally, the liner core may partially fill the first lumen such that a clearance exists between an outer surface of the liner core and an inner wall of the first lumen, the clearance communicating with the release holes and delimiting a receptacle.
Alternatively, the outer surface of the liner core may be brought into tight contact with the inner wall of the first lumen. In this case, the outer surface of the liner core and walls of the release holes may together delimit receptacles.
Optionally, the receptacle may be filled with a drug or a mixture of a drug and a drug carrier.
Optionally, the receptacle may have a depth of from 0.02 mm to 0.2 mm.
Optionally, an outer surface of each elastic metal tube may be provided with an absorbable film, the film covering the release holes.
Optionally, the wire may be consisted of the at least one elastic metal tube.
Optionally, the wire may further include a solid metal wire.
Optionally, the release holes may be provided on an outer surface of the knitted stent.
Optionally, the release holes may be distributed at a density that is higher around both ends of the knitted stent than in a middle section of the knitted stent.
Optionally, the knitted stent may further include a connection portion arranged at an end of the knitted stent, and wherein each elastic metal tube is connected to a further wire via the connection portion.
Optionally, the wire may include at least two elastic metal tubes, wherein one of the elastic metal tubes is connected to another one of the elastic metal tubes via the connection portion.
Optionally, the wire may further include a solid metal wire, and wherein when any elastic metal tube is connected to the solid metal wire, the connection portion is formed by a bent section of the solid metal wire.
Optionally, each elastic metal tube may be made essentially of a radiopaque metal, and/or the connection portion may be made essentially of a radiopaque metal.
Optionally, each elastic metal tube may have a circular or elongated radial cross-section.
Optionally, when each elastic metal tube has a circular radial cross-section, the elastic metal tube may have an outer diameter of from 0.1 mm to 0.5 mm.
Optionally, when the first lumen of each elastic metal tube has a circular radial cross-section, the first lumen may have a diameter of from 0.05 mm to 0.45 mm.
Optionally, the release holes may have a diameter of from 0.05 mm to 0.2 mm.
The above objective is also attained by a knitted stent system according to the present invention, which includes a delivery guidewire, a delivery catheter and a knitted stent as defined in any of the preceding paragraphs. The delivery guidewire is configured to load the knitted stent thereon, and the delivery catheter defines a second lumen extending through the delivery catheter along an axial direction thereof. The second lumen is configured to accommodate both the delivery guidewire and the knitted stent.
Compared with the prior art, the knitted stent and the knitted stent system of the present invention offer the following advantages:
First, the wire(s) in the knitted stent is/are spirally coiled about an axis in an interlaced manner and include(s) at least one elastic metal tube each defining a first lumen and having a wall in which release holes in communication with the first lumen are formed. Additionally, a drug or a mixture of a drug and a drug carrier can be filled in the first lumen and released from the release holes. This solves the problem of difficulty in loading drugs arising from the use of conventional knitted stents.
Second, a liner core may be so arranged in the first lumen as to at least partially fill the first lumen. In this way, an outer surface of the liner core and walls of the release holes together delimit a receptacle in which a drug or a mixture of a drug and a drug carrier can be filled. As such, through appropriately designing the liner core's dimensions, it is not only possible to adjust a drug loading amount of the knitted stent but also to further enhance fatigue resistance and radial support of the knitted stent.
The core idea of the present invention is to provide a knitted stent that defines a drug receptacle in which a drug can be filled and can thus be used to produce a drug-loaded stent.
The stent is knitted from wire(s) spirally coiled about an axis in an interlaced manner. The wire(s) include(s) at least one elastic metal tube each defining a first lumen and having a wall in which release holes in communication with the first lumen are formed.
According to embodiments of the present invention, the elastic metal tube(s) can be formed using an existing non-expensive technique for fabricating capillaries, and forming the holes in the tube(s) can be accomplished using an established technique. All of these make it possible to produce a drug-loaded stent from the knitted stent.
Objects, advantages and features of the present invention will become apparent upon reading the following more detailed description with reference to the accompanying drawings. Note that the figures are provided in a very simplified form not necessarily presented to scale, with their only intention to facilitate convenience and clarity in explaining embodiments disclosed herein.
As used herein, the singular terms “a”, “an” and “the” include plural referents, while the term “plurality” means two or more, unless the context clearly dictates otherwise. As used herein, the term “or” is generally employed in the sense including “and/or”, unless the context clearly dictates otherwise, and the terms “mount”, “couple” and “connect” in their various forms should be interpreted in a broad sense. For example, a “connection” may refer to a fixed connection, a detachable connection, or an integrated connection, or to a mechanical connection or an electrical connection, or to a direct connection or an indirect connection with one or more elements interposed between the connected ones, or to mutual communication between the interiors of two elements or interaction between two elements. A person of ordinary skill in the art would be able to understand the various uses of these terms based upon their context, and identical or similar reference numerals will be used throughout the drawings to identify identical or similar items.
In this embodiment, each elastic metal tube 110 is spiral without sharp bends and thus free of the problem of tending to break, thereby ensuring good performance of the knitted stent 100 during use. Moreover, the first lumen of each elastic metal tube 110 can serve as a drug receptacle, which when filled with a drug makes the knitted stent 100 a drug-loaded stent. This circumvents the problem of poor geometric compliance and fatigue resistance arising from the use of conventional drug-loaded stents. Each elastic metal tube 110 may be fabricated as a hollow capillary at a cost affordable for most manufacturers.
The first lumen may be filled with a drug or a mixture of a drug and a drug carrier. The drug may be, for example, paclitaxel, rapamycin or another agent that can inhibit vascular endothelial hyperplasia. In this way, when the drug-loaded stent is deployed in a diseased blood vessel, the drug may be released from the release holes 111 and acts on the blood vessel to prevent its restenosis. The drug may be mixed with the drug carrier before they are filled in the first lumen. The drug carrier may facilitate the drug's sustained release by regulating the drug's release rate. For example, the drug may be mixed with a film solution and then filled into the first lumen. The carrier for loading the drug may be a biologically stable polymer. When the carrier is degradable, the regulation of the drug's release rate can be accomplished by adjusting the carrier's degradation rate.
Preferably, the release holes 111 are arranged across an outer surface of the knitted stent 100 so that the released drug will come into direct contact with an inner wall of the blood vessel and act on the inner wall of the blood vessel without migration into the vascular lumen. This arrangement is advantageous in that the drug can effectively act to inhibit hyperplasia on the inner wall of the blood vessel while avoiding endothelialization.
The release holes 111 are arranged to provide paths for the drug's release. Therefore, this embodiment is not limited to any particular shape of the release holes 111. The release holes 111 may be circular (as shown in
In each elastic metal tube 110, the release holes 111 may be distributed along an axial direction of the elastic metal tube 110 so that the drug can be released from various segments of the knitted stent 100. The release holes 111 may be all of the same size or not (as shown in
It will be appreciated that the knitted stent 100 may include a plurality of elastic metal tubes 110. In practical use, the liner core 112 may be disposed in the first lumen of some of the elastic metal tubes 110 as desired, or the liner core 112 may be disposed in the first lumen of all the elastic metal tubes 110 as desired.
Further, each elastic metal tube 110 may be provided over its outer surface with an absorbable film (not shown) which at least covers the release holes 111. The film is provided to prevent any loss of the drug before the knitted stent 100 is implanted into the blood vessel. When the knitted stent 100 is deployed in the blood vessel, the film can be absorbed in the blood vessel so that the release holes 111 are exposed, allowing release of the drug. The absorbable film can be polylactic acid, polyglycolic acid, a lactic acid-glycolic acid copolymer or another synthetic polymer for medical use.
For the sake of easier fabrication, each elastic metal tube 110 and the first lumen thereof are preferred to both have a circular radial cross-section. In this case, the elastic metal tube 110 may have an outer diameter of 0.1-0.5 mm and an inner diameter (i.e., a diameter of the first lumen) ranging from 0.05 mm to 0.45 mm. However, for the sake of good performance of the knitted stent 100 during use, each elastic metal tube 110 is preferred to have an elongated cross-section such as elliptic or oblong, which allows the knitted stent 100 to have a reduced wall thickness. The elongated or otherwise shaped radial cross-section may be equivalent to that of the circular radial cross-section.
Further, since it is undesirable for any elastic metal tube 110 to have sharp bends (which may augment the tendency of the elastic metal tube 110 to break), as shown in
Optionally, at least one of the elastic metal tube(s) 110, the liner core(s) 112 and the connection portion 120 may be made of a radiopaque metal to impart to the knitted stent 100 radiopacity, which is helpful in the positioning of the knitted stent 100 in the blood vessel. Examples of the radiopaque metal may include, but are not limited to, tantalum, platinum, gold, platinum-tungsten alloys or platinum-iridium alloys.
In other embodiments, as shown in
Further, in this embodiment, in case of the wire(s) including at least two elastic metal tubes 110, one of the elastic metal tubes 110 may be connected to another or the other elastic metal tube 110 by a connection portion 120. Alternatively, one of the elastic metal tubes 110 may be connected to a metal wire 130. In the latter case, a bent end portion of the metal wire 130 may serve as a connection portion 120. Of course, the metal wire(s) 130 may also be formed of a radiopaque metal.
On the basis of the knitted stent 100 as defined above, in embodiments of the present invention, there is also provided a knitted stent system include a delivery guidewire, a delivery catheter and the knitted stent. The delivery guidewire is configured to deliver the knitted stent (by disposing the knitted stent over the delivery guidewire), and the delivery catheter defines a second lumen, which extends through the catheter along an axial direction thereof and is configured to accommodate both the delivery guidewire and the knitted stent.
The knitted stent according to the present invention is knitted from wire(s) including elastic metal tube(s) each defining a first lumen that can serve as a drug receptacle for the knitted stent. In this way, the knitted stent can be used as a base of a drug-loaded stent, and the problem of poor mechanical properties arising from the use of conventional drug-loaded stents is solved.
Although the present invention has been disclosed above, it is not limited to the above disclosure. Those skilled in the art can make various modifications and variations to the present invention without departing from the spirit and scope thereof. Accordingly, the invention is intended to embrace all such modifications and variations if they fall within the scope of the appended claims and equivalents thereof.
Number | Date | Country | Kind |
---|---|---|---|
201911360870.9 | Dec 2019 | CN | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/CN2020/114612 | 9/10/2020 | WO |